Virtu KCG Holdings’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Virtu KCG Holdings’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,588	Closed	-$74K	–	4045
2016 Q4	$74K	Sell	2,588 -761	-23%	-$21.3K	﹤0.01%	3007
2016 Q3	$70K	Buy	3,349 +1,885	+129%	+$33.8K	﹤0.01%	2726
2016 Q2	$23K	Buy	+1,464	New	+$26.7K	﹤0.01%	2786
2015 Q3	–	Sell	-2,512	Closed	-$74K	–	4047
2015 Q2	$74K	Buy	+2,512	New	+$75.9K	﹤0.01%	2995
2015 Q1	–	Sell	-3,948	Closed	-$89K	–	4180
2014 Q4	$89K	Buy	+3,948	New	+$107K	﹤0.01%	3272
2014 Q1	–	Sell	-3,262	Closed	-$120K	–	4318
2013 Q4	$120K	Buy	3,262 +1,581	+94%	+$42.4K	﹤0.01%	3388
2013 Q3	$33K	Buy	+1,681	New	+$33K	﹤0.01%	3564

Other funds holding IPCI

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ATC

Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's IPCI Position: Q1 2017 in Review

Virtu KCG Holdings sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2017, closing a stake of 2,588 shares — an estimated $74K sold.

Virtu KCG Holdings first reported a position in IPCI in Q3 2013 and held it in 7 quarters. The position peaked at $120K in Q4 2013. 22 funds tracked by Wall St. Rank hold IPCI as of Q1 2017.

Virtu KCG Holdings reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2017 after selling out during the quarter.
Virtu KCG Holdings sold 2,588 Intellipharmaceuticals International Inc. shares in Q1 2017, an estimated $74K.
Virtu KCG Holdings first reported a position in Intellipharmaceuticals International Inc. in Q3 2013 and held it in 7 quarters.
Virtu KCG Holdings's Intellipharmaceuticals International Inc. position peaked at $120K in Q4 2013.
22 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.